Euronext Growth Brussels
In addition to ImmuPharma’s listing on London’s AIM, the Company, since 19 December 2019, has a dual listing with Euronext Growth Brussels and shares can be traded on this market under the ticker ‘ALIMM’. This dual listing on Euronext allows ImmuPharma to join the number one European stock exchange for Life Sciences and the world’s second biggest for biotech companies after the United States. The information disclosed in this section are related to regulatory requirements applicable to companies listed on Euronext Growth Brussels.
Please click on the link below to access the Company’s ‘Information Note’ as required by the Euronext Growth Market Rules Book and Belgian financial regulations (17 November 2019). For further regulatory information on ImmuPharma, pursuant to its AIM regulations and disclosure, please click here
Information Note click here
Financial calendar click here